Trial Profile
Duloxetine for the treatment of obsessive compulsive disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 15 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Apr 2013 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 19 Jul 2011 Planned End Date changed from 1 Aug 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.